These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A systematic review and economic evaluation of statins for the prevention of coronary events. Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of high-dose rosuvastatin preloading in patients undergoing percutaneous coronary intervention: a meta-analysis of fourteen randomized controlled trials. Pan Y; Tan Y; Li B; Li X Lipids Health Dis; 2015 Aug; 14():97. PubMed ID: 26306625 [TBL] [Abstract][Full Text] [Related]
7. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials). Murphy SA; Cannon CP; Wiviott SD; de Lemos JA; Blazing MA; McCabe CH; Califf RM; Braunwald E Am J Cardiol; 2007 Oct; 100(7):1047-51. PubMed ID: 17884359 [TBL] [Abstract][Full Text] [Related]
8. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events. Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766 [TBL] [Abstract][Full Text] [Related]
9. Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials. Kang S; Liu Y; Liu XB Clin Ther; 2013 Aug; 35(8):1125-36. PubMed ID: 23932462 [TBL] [Abstract][Full Text] [Related]
10. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Tunnicliffe DJ; Palmer SC; Cashmore BA; Saglimbene VM; Krishnasamy R; Lambert K; Johnson DW; Craig JC; Strippoli GF Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007784. PubMed ID: 38018702 [TBL] [Abstract][Full Text] [Related]
11. Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials. Bavry AA; Mood GR; Kumbhani DJ; Borek PP; Askari AT; Bhatt DL Am J Cardiovasc Drugs; 2007; 7(2):135-41. PubMed ID: 17503884 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety evaluation of intensive statin therapy in older patients with coronary heart disease: a systematic review and meta-analysis. Yan YL; Qiu B; Hu LJ; Jing XD; Liu YJ; Deng SB; Du JL; She Q Eur J Clin Pharmacol; 2013 Dec; 69(12):2001-9. PubMed ID: 23942733 [TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. Cannon CP; Steinberg BA; Murphy SA; Mega JL; Braunwald E J Am Coll Cardiol; 2006 Aug; 48(3):438-45. PubMed ID: 16875966 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Cholesterol Treatment Trialists' Collaboration Lancet; 2019 Feb; 393(10170):407-415. PubMed ID: 30712900 [TBL] [Abstract][Full Text] [Related]
16. Exercise-based cardiac rehabilitation for coronary heart disease. Anderson L; Thompson DR; Oldridge N; Zwisler AD; Rees K; Martin N; Taylor RS Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD001800. PubMed ID: 26730878 [TBL] [Abstract][Full Text] [Related]
17. Interpretation of the evidence for the efficacy and safety of statin therapy. Collins R; Reith C; Emberson J; Armitage J; Baigent C; Blackwell L; Blumenthal R; Danesh J; Smith GD; DeMets D; Evans S; Law M; MacMahon S; Martin S; Neal B; Poulter N; Preiss D; Ridker P; Roberts I; Rodgers A; Sandercock P; Schulz K; Sever P; Simes J; Smeeth L; Wald N; Yusuf S; Peto R Lancet; 2016 Nov; 388(10059):2532-2561. PubMed ID: 27616593 [TBL] [Abstract][Full Text] [Related]
18. Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study. Scirica BM; Morrow DA; Cannon CP; Ray KK; Sabatine MS; Jarolim P; Shui A; McCabe CH; Braunwald E; J Am Coll Cardiol; 2006 Jun; 47(11):2326-31. PubMed ID: 16750703 [TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials. Josan K; Majumdar SR; McAlister FA CMAJ; 2008 Feb; 178(5):576-84. PubMed ID: 18299547 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. ; Baigent C; Blackwell L; Emberson J; Holland LE; Reith C; Bhala N; Peto R; Barnes EH; Keech A; Simes J; Collins R Lancet; 2010 Nov; 376(9753):1670-81. PubMed ID: 21067804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]